Risk factors for pneumocystis pneumonia
in giant cell arteritis: a single-centre cohort study.
Serum and BAL beta-D-glucan for the diagnosis of Pneumocystis pneumonia
in HIV positive patients.
Characteristics and clinical relevance of the quantitative touch-down major surface glycoprotein polymerase chain reaction in the diagnosis of Pneumocystis pneumonia
Current insights into the biology and pathogenesis of Pneumocystis pneumonia
(PCP) is an important and opportunistic pulmonary infection in Acquired Immune Deficiency Syndrome (AIDS) patients, which is caused by an odd fungus called Pneumocystis jirovecii, especially in AIDS patients with CD4[sup]+ T-cell < 0.
Serum indicators for the diagnosis of pneumocystis pneumonia
," Chest, vol.
In the 3 cases described here, the specific conditions the treatment teams failed to identify as indicators of HIV infection were thrombocytopenia, pneumocystis pneumonia
, herpes zoster, and cryptococcal meningitis.
This stage is often complicated by an infection of the lung known as pneumocystis pneumonia
, severe weight loss, a type of cancer known as Kaposi's sarcoma, or other AIDS-defining conditions, she added.
We describe a patient with VAP caused by another opportunistic organism, Pneumocystis jirovecii, in the absence of traditional risk factors for Pneumocystis pneumonia
These diseases include pneumocystis pneumonia
(PCP), tuberculosis and toxoplasmosis.
The most common underlying causes of death in HIV-positive pregnant women were tuberculosis, pneumonia, pneumocystis pneumonia
Two case series explore common complications of advanced HIV disease, including CMV retinitis (Laher), suggesting reasonable outcomes despite the absence of systemic therapy, and Pneumocystis pneumonia
(Shaddock), providing evidence for lung fibrosis in individuals with advanced disease requiring ventilation.
Indeed, this year - June 5th, to be precise--marks the 30th anniversary of the first published article describing an increased incidence of pneumocystis pneumonia
in previously fit young men living in the United States .
The HIV-infected partners were randomly assigned to either immediately start triple or quadruple antiretroviral therapy, regardless of CD4 count, or to a deferred-treatment group that started therapy only after their counts dropped below 250 cells/mcL, or they developed pneumocystis pneumonia
, or another AIDS-related event.
But times have changed hugely since 1981 when doctors in the United States became aware of HIV/AIDS after noticing a sudden increase in rare diseases such as Kaposi's sarcoma and pneumocystis pneumonia